On Oct. 6, 2020, Hologic announced that two studies in the Journal of Clinical Microbiology demonstrated the utility of Hologic’s Panther platform and Aptima HIV-1 Quant assay in research related to potentially curing HIV-infected individuals.

Hologic scientists collaborated on the studies1,2 with researchers at Vitalant Research Institute, the University of California, San Francisco, the University of California, San Diego, and the University of Pittsburgh.